A class of interleukin-2-dependent T-cell clones, isolated from a murine fetal thymus, was previously shown to suppress the induction of cytotoxic responses to alloantigens (H.-S. Teh, M. Ho, and W. R. McMaster, J. Immunol. 135:1582-1588. In that article, the immunosuppressive properties of these T-cell clones were shown to be a direct consequence of infection by Mycoplasma hyorhinis. Suppression of cytotoxic responses was mediated by both the mycoplasmas and a 200-kilodalton factor present in supernatants of infected cultures. This factor was sensitive to proteases but was resistant to heating to 60°C for 1 h and to incubation on ice at pH 2 or pH 14 for 4 h. The production of suppressor factor in infected cultures was independent of the viability or the protein synthesis capability of the mammalian cells, suggesting that it was produced by M. hyorhinis. The factor was most suppressive when it was added during the early stages of the cytotoxic response. Its suppressive effects on cytotoxic responses were not reversed by the addition of an excess of recombinant interleukin-2. This factor also suppressed mitogenic responses to lipopolysaccharide. However, it is not a growth inhibitor since it did not affect the proliferation of tumor cell lines. A simple method for detecting M. hyorhinis in the infected T-cell clones and for eliminating it is described.
The technique of long-term continuous cell culture has assumed an increasingly important position in immunological research. The delineation of the various immunoregulatory or effector functions that are performed by T lymphocytes is greatly facilitated by the availability of antigen-specific T-cell clones and hybridomas. B-cell hybridomas are invaluable for the production of specific monoclonal antibodies. Certain long-term cell lines or tumor lines can also be used to produce large quantities of lymphokines with important immunoregulatory properties. For instance, interleukin-1 (IL-1) has been purified to apparent homogeneity from culture supematants of P388D1 macrophage cells that were superinduced with phorbol myristic acetate (PMA) and cycloheximide (15) . Similarly, IL-2 can be produced in large amounts and purified to homogeneity from PMAstimulated EL4.IL-2 lymphoma cells (6, 19) ; IL-3 has been purified to apparent homogeneity from conditioned media in which WEHI-3 myelomonocyte cells were cultured (9) .
Long-term cultures are exposed to an increased risk of contamination by microorganisms. Contamination by mycoplasmas is the most insidious of bacterial infections since certain mycoplasmal infections are not accompanied by visible changes in the morphology or growth pattern of the infected cells. However, it is well documented that mycoplasmal infections can lead to the alteration of a broad range of mammalian cell activities and functions (14) . Some of these alterations can be very detrimental to various immunological procedures. For instance, mycoplasmas or their products have been shown to inhibit the stimulation of lymphocytes by allogeneic cells or mitogens (1, 4, 22) . Most mycoplasmal strains possess nucleoside phosphorylases which catalyze the conversion of nucleosides to their respective free bases; as much as 95% of exogenously added labeled nucleosides can be converted within 60 min (17) . These properties have profound effects on the measurement of DNA and RNA synthesis in mycoplasma-infected mam-* Corresponding author. malian cell cultures (8, 17, 20) . Infection by Mycoplasma hyorhinis has been shown to be responsible for the inability to isolate somatic cell hybrids in HAT (hypoxanthine-aminopterin-thymidine) selection media (26) . Monoclonal antibodies to M. hyorhinis have also been inadvertently produced as a consequence of using mycoplasma-infected human tumor cell lines as immunogens (27) . Mycoplasmas and their products can also serve as mitogens for both T (5, 29) and B lymphocytes (18) . Such stimulatory or inhibitory properties of mycoplasmas and of their products may have contributed to the increasing number of novel "lymphokines" that affect B-and T-cell differentiation.
A variety of techniques for the detection of mycoplasmas in mammalian cell cultures has been described. These techniques include electron microscopy, immunofluorescence, autoradiography, fluorescent-dye staining of DNA, and bacteriologic culture (14) . Other techniques are based on the detection of enzymes unique to mycoplasmas, e.g., the conversion of arginine to citrulline by arginine deaminase (2) and the measurement of pyrimidine and purine phosphorylase activities in infected cell lines (7, 12) . Mycoplasmal infection also leads to a dramatic decrease in the ratio of uridine to uracil incorporated in infected cultures (21) . A simple method of detection based on toxicity has been developed (13) . It is mediated by the conversion of 6-methylpurine deoxyriboside (6-MPDR) by adenosine phosphorylase, an enzyme present in significant amounts in most mycoplasmal strains, into two toxic antimetabolites: 6-methylpurine and 6-methylpurine riboside.
In this article, evidence is presented that the immunosuppressive properties of a class of fetal thymus-derived T-cell clones (24) were a consequence of infection by M. hyorhinis. More interestingly, culture supernatants of mycoplasmainfected cells were found to contain a 200-kilodalton molecule with immunosuppressive properties. The properties of this molecule and its mode of action in cytotoxic responses, as well as data supporting its mycoplasmal origin, are described.
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MATERIALS AND METHODS
Mouse strains. C57BL/6J (B6), DBA/2J (D2), (C57BL/6J x DBA/2J)F1 (BDF1), and CBA/J (CBA) mice were bred in the animal unit of this department. Cell lines. P815 (H-2d) mastocytoma cells, 6-thioguanineresistant BW5147 (H-2k) lymphoma cells, and 8-azaguanineresistant NS-1 mouse myeloma cells (H-2d) were obtained from the American Type Culture Collection, Rockville, Md., and maintained as cultured cell lines. EL4.IL-2, a variant cell line of EL4 (H-2b) that produces IL-2 upon stimulation with PMA (6), was obtained from Vern Paetkau, Department of Biochemistry, University of Alberta, Edmonton, Alberta, Canada. One fetal thymus cell clone, C2, was isolated and maintained in medium supplemented with EL4.PMA (see below) as previously described (24) .
IL-2. Human recombinant IL-2 (rIL-2) (lot no. LP-315 from Escherichia coli) was provided by the Cetus Corporation, Emeryville, Calif. (28) . The rIL-2 was 99% pure as assayed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and contained less than 0.01 ng of endotoxin per 1.5 x 106 U. One unit of IL-2 is defined as the amount of rIL-2 required to cause 50% maximal proliferation of an IL-2-dependent T cell line cultured at 104 cells per 0.2 ml for 2 days. IL-2-containing supernatants were prepared by culturing EL4.IL-2 cells (106/ml) with PMA (10 ng/ml) as previously described (6, 19) . These supernatants, referred to as EL4.PMA, contained an IL-2 activity of about 500 U/ml when assessed against the rIL-2 standards.
Cell cultures and assays. The culture medium was RPMI 1640 supplemented with 10% fetal bovine serum (Bocknek, Rexdale, Ontario, Canada), 25 mM NaHCO3, 10 mM HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid) buffer (pH 7.2), 5 x 10-' M 2-mercaptoethanol, 30 ,ug of glutamine per ml, 50 U of penicillin per ml, and 50 ,ug of streptomycin per ml. All cultures were incubated at 37°C in humid air containing 5% CO2. For 
RESULTS
Immunosuppressive factor contained in supernatants from mycoplasma-infected C2 cells. Naturally occurring suppressor cells have been shown to exist in the liver, spleen, and thymus of fetal and newborn mice (3, 16, 23) . We previously described a procedure for the isolation of a class of suppressor T-cell clones from murine fetal thymus (24) . These suppressor clones have a Thy-1+ Lyt-2+ Lyt-1-H-2K/D-I-A-cell surface phenotype and are dependent on IL-2 for growth. The fetal thymus-derived suppressor clones and supernatant factors derived from them suppress the induction of cytotoxic T-lymphocyte (CTL) responses to alloantigens (24) . By using the 6-MPDR toxicity test described in Materials and Methods, it was found that all of the fetal thymus clones used in our previous study were infected with mycoplasma. One of the fetal thymus clones, referred to as C2, was completely freed of mycoplasmal infection upon intraperitoneal passage through BDF1 mice. The strain of mycoplasma that infected C2 cells was identified as M. hyorhinis by the Veterinary Services Laboratory, Guelph, Ontario, Canada.
The immunosuppressive properties of culture supernatants derived from mycoplasma-infected or uninfected C2 cells were assessed by using the CTL assay system as previously described (25) . It method to determine whether suppression of CTL responses by supernatants from infected cultures was due to mycoplasmas or to a soluble factor in these supernatants or to both. A 10-ml amount of culture supematant from infected C2 cells was collected. Of this 10 ml, 5 ml was filtered twice through 0.1-p.m-pore-size filters. By using the 6-MPDR test, it was shown that the unifitered supernatant portion was mycoplasma positive and that the filtered supernatant portion was mycoplasma negative. The suppressive activity of the filtered and unfiltered supernatant portions was determined by using the CTL assay; the results are shown in Table 2 . Both the unfiltered and the filtered supernatant portions were able to suppress the CTL response. The unfiltered supernatant portion was about 30 times more suppressive than the filtered supernatant portion since almost-equivalent re- sponses were observed with a 0.3% concentration of unfiltered supernatant and a 10% concentration of filtered supernatant. In a separate experiment, heating of the unfiltered supernatant portion for 1 h iXt 60°C also reduced its suppressive activity by about 30-fold (data not shown). Since filtration (18) and heating to 60°C for 1 h (14) were effective in eliminating mycoplasmas, these data suggest that suppression of the CTL response was mediated by the mycoplasmas themselves as well as by a suppressor factor (SF) that was resistant to heating to 600C for 1 h. The mycoplasmas appeared to be a more potent suppressor than SF.
Mechanism of action of SF. The kinetics of the action of $F was determined by including SF for various amounts of time during the 120-h incubation period. As indicated in Table 3 , SF was maximally suppressive when it was present either for the entire 5-day culture period or during the first 48 h of the culture period. Addition of SF after 72 h or only during the first 24 h did not lead to suppression of the CTL response. This suggests that SF suppressed the inductive phase rather than the later stages of the CTL response.
SF could suppress CTL responses to alloantigens even in the presence of EL4.PMA, which coptained IL-2 (Fig 1,  Tables 1 and 2 ). This suggests that the suppression of CTL responses by SF could not be reversed by IL-2. This a Culture conditions were as described in the legend to Fig. 1 except that the cultures were not supplemented with 1% EL4.PMA and a D2 LN cell dose of 5 x 104 per well was used.
b Mycoplasma-free SF was prepared as described in Table 2 , footnote a, and added at 10%. Culture conditions were as described in the legend to Fig. 1 except that the indicated units of rIL-2 were substituted for EL4.PMA. Mycoplasma-free SF was prepared as described in Table 2 and added to the cultures at a final concentration of 10% (vol/vol).
conclusion was confirmed by the observation that the suppression of CTL responses by SF could not be reversed by the addition of an excess amount (40 U/ml) of rIL-2 (Fig. 2) .
We reported earlier that EL4.PMA could induce normal spleen cells to proliferate and differentiate into CTL in the absence of stimulation with a specific antigen or mitogen (25) . We Table 2 . It was concentrated sixfold by filtration through an Amicon filter (5,000-molecular-weight cutoff). One ml of the concentrated SF was loaded onto a 1-by 120-cm Sephadex G-150 column. The column was eluted with phosphatebuffered saline by using a flow rate of 4 ml/h. Fractions (2 ml) were collected and tested at a 1/10 dilution for suppressor activity in the CTL assay as described in Table 3 likely that SF preferentially interferes with activation signals that are mediated through the T-cell receptor complex.
Properties of SF. The apparent molecular mass of SF was determined by chromatography on a Sephadex G-150 column (Pharmacia, Inc., Piscataway, N.J.) (Fig. 3) . The eluted fractions were assessed for suppressive activity by using the CTL assay. It was found that a major peak of suppressive activity eluted with an apparent molecular mass of 200 kilodaltons. Minor peaks of suppressive activity eluting at lower molecular masses were also observed. It remains to be determined whether the lower-molecular-mass factors are breakdown products of the 200-kilodalton factor or of unrelated factors.
SF was subjected to various treatments prior to assay for suppressive properties in the CTL assay. It was found that SF was resistant to heating at 60°C for 1 h and incubation at pH 2 or pH 12 for 4 h; however, it was sensitive to digestion by proteinase K or chymotrypsin ( Table 5 ). The resistance of SF to heating at 60°C for 1 h was a further indication that suppression by SF was not due to residual mycoplasmas since these organisms are extremely sensitive to heat treat- a A 1-ml amount of SF, prepared as described in Table 2 , was treated as indicated and used at a final concentration of 3% (vol/vol). Treatments of SF at pH 2 or 12 were done on ice, and the pH was readjusted to pH 7.0 at the end of the 4-h period. Proteinase K (Sigma) and chymotrypsin (Sigma) were used at 20 and 50 pg/ml, respectively. A 1-mi amount of SF was digested with the indicated protease for 3 h at 37°C. The reaction was stopped by adding 1 ml of fetal bovine serum.
b Culture and assay conditions were as described in Table 3 , footnote a.
ment (14) . Control experiments were also performed to show that the inclusion of an equivalent amount of proteases had no effect on the CTL response (data not shown). Sensitivity to these two proteases suggests that SF is likely to be a protein.
The effects of SF on mitogenic responses to lipopolysaccharide (LPS) and on the proliferation of tumor cells were determined (Table 6 ). It was found that SF inhibited the mitogenic response to LPS. However, the proliferation of mastocytoma cells (P815), T lymphoma cells (EL4.IL-2 and BW5147), and myeloma cells (NS-1) was unaffected by SF. This study suggests that SF is not an inhibitor of DNA synthesis but that it can suppress the proliferation of LPSstimulated spleen cells.
Mycoplasmal origin of SF. SF could be produced either by mycoplasmas or by the mammalian cells as a result of mycoplasmal infection. Alternatively, SF could be a mycoplasma product which had to be modified by host cells prior to becoming a suppressive molecule. To test these possibilities, a number of different mycoplasma-free tumor cell lines were infected with 1% (vol/vol) mycoplasma-containing culture supernatant from infected C2 cells. Supernatants from intentionally infected cell lines were harvested 4 days later, The 4-day supernatants from these cultures were harvested and filtered twice over 0.1-,um-pore-size filters before being tested for suppressor activity. All filtered supernatants were found to be mycoplasma negative. c Data in parentheses indicate percent suppression.
filtered through 0.1-,um-pore-size filters to remove mycoplasmas, and tested for SF activity in the CTL assay. It is clear from the data in Table 7 that SF activity was found in supernatants of intentionally infected P815, EL4.IL-2, NS-1, and BW5147 cells. The SF activity in the mycoplasmacontaining C2 supernatant used to infect the tumor cell lines was determined by filtering this supernatant twice through 0.1-p.m-pore-size filters and titrated in the CTL assay. A suppression of 86 and 42% was observed when this filtered supernatant was added at concentrations of 10 and 1%, respectively. Since filtered supernatant from the intentionally infected cell lines gave about 100% suppression of the CTL response when used at 10% (Table 7) , and since insignificant amounts of SF were introduced with the original inoculum, there was an increase in SF activity of much greater than 100-fold during the 4-day culture period. Equiv- b Culture and assay conditions were the same as in Table 3 , footnote a. Control cultures without added SF yielded a mean specific lysis value of 37.7%iand a standard error of 4.1%. alent amounts of supernatant from non-mycoplasma-infected cell lines were uniformly nonsuppressive in the CTL assay (data not shown). Thus, unless one postulates that mycoplasmas could induce different types of mammalian cells to produce the same suppressor molecule, these data would argue for the mycoplasmal origin of SF.
If SF was produced by mammalian cells, its synthesis should depend on metabolically active mammalian cells. However, SF production was not dependent on the viability or the protein synthesis capabilityof the host cells (Table 8) . Thus, SF was produced when mycoplasma-free P815 cells were intentionally infected with mycoplasma, regardless of whether the P815 cells were exponentially growing (column headed Untreated, Table 8 ), heat killed (56°C, 1 h), or pretreated with cycloheximide (cycloheximide). The P815 cells pretreated with cycloheximide were shown to lack protein or DNA synthesis capability after the treatment (data not shown). The amount of SF produced in heat-killed or cycloheximide-treated P815 cultures was again more than 100-fold greater than that present in the initial inoculum.
There was also a greater-than-100-fold increase in SF activity when mycoplasma-containing C2 supernatant was used to inoculate culture medium alone (data similar to those in column headed Untreated, Table 8 ). Supernatants from P815 cells treated with the same concentration of cycloheximide or heat killed, but not intentionally infected with mycoplasma, did hot contain any SF activity (data not shown). Thus, the SF activity observed in supernatants from mycoplasma-infected P815 cultures was not due to residual cycloheximide or toxic substances released from heat-killed P815 cells. These data suggest that SF is produced by mycoplasmas and not by the infected host cells.
DISCUSSION
A class of IL-2-dependent suppressor T-cell clones, isolated from murine fetal thymus, has been shown to suppress the induction of CTL responses to alloantigens (24) . In the present article, evidence is presented to indicate that the suppressive properties of this class of suppressor T-cell clones were a direct consequence of mycoplasmal infection. Thus, cells and culture supernatants from an infected fetal thymus-derived T-cell clone, C2, were able to suppress cytotoxic responses to alloantigens. Infected C2 cells, decontaminated by intraperitoneal passage through semisyngeneic mice, were no longer suppressive and did not produce any SF. When the decontaminated C2 cells were intentionally reinfected with mycoplasma, cells and culture supernatants derived from the reinfected cells were again suppressive in the CTL assay.
A modified 6-MPDR toxicity test (13) (8, 17, 20) . It is therefore clear that mycoplasmas have to be removed from the culture supernatants before these supernatants can be assessed for the presence of biologically active molecules. Filtration through 0.1-p,m-pore-size filters offers a simple method for the elimination of mycoplasmas from culture supernatants.
A human T-cell line has been shown to produce a factor that is fairly similar to SF (10, 11) . This human suppressoractivating factor (SAF) referred to as SAF, is constitutively produced by the T-cell line. SAF suppresses proliferative responses to T-cell mitogens, antibody responses that are induced by pokeweed mitogen, as well as CTL responses to alloantigens (25) . SAF can be used to induce more suppressor factor production in T cells; the increased suppressor factor production is not dependent on the protein or DNA synthesis capability or on the viability of the T cells (11) .
Since that human T-cell line was not tested for mycoplasmal infection, it is possible that the SAF-associated properties of that human T-cell line are also a consequence of mycoplasmal infection.
The present study and the other studies described in this article demonstrate the broad range of immunological functions that can be affected as a result of mycoplasmal infections. These effects can range from suppression of cytotoxic responses to mitogenic effects of mycoplasmas and their products on T and B cells. A soluble factor, derived from M. arthritidis, has been shown to be mitogenic only for T cells from H-2k or H-2d mice, not for those from H-2b, H-2q, or H-2s mice (5, 29) . Thus, differential stimulation or suppression of murine lymphocytes by factors in culture supernatant can no longer be taken as evidence for the lack of mycoplasmal contamination. However, despite the many undesirable side effects arising from infection of long-term cultured cell lines by mycoplasmas, it is clear that mycoplasmas can produce a number of molecules with interesting immunoregulatory properties. Further studies on the structure and mode of action of these molecules may yield unexpected rewards.
